Global COVID-19 vaccine supply “incredibly tight”, COVAX needs funds – Gavi

(Reuters) – The global supply of COVID-19 vaccine is “incredibly tight” and the COVAX dose-sharing facility is unlikely to procure much more supply in 2021 than doses already reserved, the Gavi vaccine alliance ceo Seth Berkley said on Thursday.

“We urgently need commitments of a further $2 billion from donors and $1 billion from countries supported by multilateral development banks. Included in the $2 billion we ask for is $150 million from the private sector,” Berkley told an event, referring to a funding target for June.

People mark a container holding doses of the AstraZeneca’s vaccine against the coronavirus disease (COVID-19) that arrived under the COVAX scheme, in Alajuela, on the outskirts of San Jose, Costa Rica April 7, 2021. REUTERS/Mayela Lopez

Stanley Erck, Novavax (NVAX.O) ceo, said that the U.S.-based company had vaccine production capabilities in more than 20 facilities and that it was “well on our way to securing regulatory authorizations around the world”.

Our Standards: The Thomson Reuters Trust Principles.


Reuters source: